We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Helps Identify Liver Cirrhosis Using Electronic Health Records

By HospiMedica International staff writers
Posted on 28 Mar 2023

Cirrhosis, which is the end-stage of chronic liver disease and ranked as the 9th leading cause of death in 2021 by the Centers for Disease Control and Prevention, can result from various forms of liver damage and disease. More...

Identifying patients who are likely to progress to cirrhosis has been difficult. However, early diagnosis could improve disease management. Artificial intelligence (AI) can be used to collect and analyze vast amounts of data, often from the electronic health record (EHR) containing the patient’s health history. While computers can easily interpret data entered into forms, it has been challenging to extract information from narrative text, such as clinician notes or discharge summaries. Previous attempts to extract information relied on keyword searches, which required input from a clinician familiar with the disease and multiple rounds of trial and error.

Researchers at the Medical University of South Carolina (MUSC, Charleston, SC, USA) have created a new AI method to automate the detection of liver cirrhosis by utilizing extensive data from EHRs. The AI model, called a convolutional neural network (CNN), mimics the neurons in the brain and was trained on EHRs of patients previously diagnosed with cirrhosis. By analyzing information embedded in narrative text and utilizing multiple layers of artificial neurons, the neural network can extract features and patterns to help identify cirrhosis.

After training on patient records manually reviewed to confirm cirrhosis diagnosis, the researchers applied their deep learning-based AI model that does not require prompts to a new set of health records. The model demonstrated exceptional success in identifying cirrhosis patients based solely on narrative text in clinician notes. Specifically, the trained CNN model achieved a precision rate of 97% when identifying cirrhosis patients using clinical text found in patient discharge summaries alone. While AI and machine learning have the potential to revolutionize the medical field, the researchers believe that these models are not meant to replace clinical judgment but rather to support and enhance it. Therefore, clinicians remain responsible for solving the case, with AI serving as a powerful tool to assist them, according to the researchers.

“The nice thing about using deep learning models is that the model learns from the examples you give it, without training it to look for certain words,” said Jihad Obeid, M.D., a professor in Biomedical Informatics at MUSC. “I think it's exciting that it was successful at identifying cirrhosis using just the text in the discharge summaries, as is the idea of taking it to the next level to see if we can apply it for earlier identification.”

Related Links:
MUSC


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
Immobilization System
Cranial 4Pi Immobilization
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Visual Abstract (Andrea Farolfi et al., Journal of Nuclear Medicine, 2026. DOI: 10.2967/jnumed.126.272108)

PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI

Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.